Showing results (31-40 of 560) with videos related to
Sort By:
Pageof 56
Current Cancer Drug Targets|August 20, 2010
Predictive molecular markers of response to epidermal growth factor receptor(EGFR) family-targeted therapiesSarah Barton, Naureen Starling, Charles SwantonJournal of Gastroenterology|August 5, 2020
Targeting the immune milieu in gastrointestinal cancersFiona Turkes, Justin Mencel, Naureen StarlingCancers|June 28, 2023
Targeted Therapies and Developing Precision Medicine in Gastric CancerRille Pihlak, Caroline Fong, Naureen StarlingCurrent Oncology (Toronto, Ont.)|November 26, 2025
New Horizons with Growth Differentiation Factor 15 in Oncology: From Cancer Cachexia and Tumour Immunity to Novel Therapeutic StrategiesKeiji Sugiyama, Naureen Starling, Ian ChauExpert Review of Gastroenterology & Hepatology|August 17, 2021
Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinomaShubham Gupta, Sikandar Khan, Michal Kawka, et al.European Journal of Cancer (Oxford, England : 1990)|August 4, 2020
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)Avani Athauda, Matthew Nankivell, Ruth E Langley, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 14, 2025
Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinomaKeiji Sugiyama, Sacheen Kumar, Asif Chaudry, et al.The Oncologist|May 7, 2026
Prolonged response to Pembrolizumab in BRAFV600E microsatellite stable metastatic colorectal cancer following an increase in tumour mutational burdenYu-Hsuen Yang, Naureen Starling, Elizabeth CartwrightThe Oncologist|October 16, 2016
Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography ImagingKhurum Khan, Avani Athauda, Katharine Aitken, et al.The New England Journal of Medicine|January 4, 2008
Capecitabine and oxaliplatin for advanced esophagogastric cancerDavid Cunningham, Naureen Starling, Sheela Rao, et al.Pageof 56